Predictive factors for recurrence of retroperitoneal sarcoma_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

Guo Jinhui , CHA Lichao , HE Xiangyang ,  QIU Fabo

Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, P. R. China;

Corresponding author：

QIU Fabo, Email: Qiufabo@sina.com

Keywords：

retroperitoneal sarcoma; recurrence; histological type; forecast; review

DOI：

10.7507/1007-9424.201903007

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To summarize the predictive factors of recurrence of retroperitoneal sarcoma.Methods The literatures on the recurrence of retroperitoneal sarcoma at home and abroad were reviewed and analyzed.Results Tumor size, margin negative resection, tumor grade, multifocal, and histological types were important predictors of the recurrence of retroperitoneal sarcoma. In addition, combined organ resection, diversity of tumor growth patterns, and tumor-free surgical techniques could also affect the recurrence of retroperitoneal sarcoma.Conclusion Understanding the predictive factors of the recurrence of retroperitoneal sarcoma is of great significance to guide surgeons to understand and recognize the disease, to reduce the recurrence of retroperitoneal sarcoma.

Citation： Guo Jinhui, CHA Lichao, HE Xiangyang, QIU Fabo. Predictive factors for recurrence of retroperitoneal sarcoma. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2019, 26(9): 1141-1144. doi: 10.7507/1007-9424.201903007 Copy

1.	Blair AB, Reames BN, Singh J, et al. Resection of retroperitoneal sarcoma en-bloc with inferior vena cava: 20 year outcomes of a single institution. J Surg Oncol, 2018, 118(1): 127-137.
2.	Tseng WW, Seo HJ, Pollock RE, et al. Historical perspectives and future directions in the surgical management of retroperitoneal sarcoma. J Surg Oncol, 2018, 117(1): 7-11.
3.	Trans-Atlantic RPS Working Group. Management of primary retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group. Ann Surg Oncol, 2015, 22(1): 256-263.
4.	Nussbaum DP, Rushing CN, Lane WO, et al. Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database. Lancet Oncol, 2016, 17(7): 966-975.
5.	Ng D, Swallow CJ. Decision-making for palliative versus curative intent treatment of retroperitoneal sarcoma (RPS). Chin Clin Oncol, 2018, 7(4): 40.
6.	Baldini E. Retroperitoneal sarcoma: setting the stage for treatment strategies tailored to histologic subtype and other patient and tumor factors. Int J Radiat Oncol Biol Phys, 2017, 99(2): 292-295.
7.	Tan MC, Brennan MF, Kuk D, et al. Histology-based classification predicts pattern of recurrence and improves risk stratification in primary retroperitoneal sarcoma. Ann Surg, 2016, 263(3): 593-600.
8.	Honoré C, Faron M, Mir O, et al. Management of locoregional recurrence after radical resection of a primary nonmetastatic retroperitoneal soft tissue sarcoma: the Gustave Roussy experience. J Surg Oncol, 2018, 118(8): 1318-1325.
9.	Zaidi MY, Canter R, Cardona K. Post-operative surveillance in retroperitoneal soft tissue sarcoma: the importance of tumor histology in guiding strategy. J Surg Oncol, 2018, 117(1): 99-104.
10.	Fairweather M, Wang J, Jo VY, et al. Incidence and adverse prognostic implications of histopathologic organ invasion in primary retroperitoneal sarcoma. J Am Coll Surg, 2017, 224(5): 876-883.
11.	Bagaria SP, Gabriel E, Mann GN. Multiply recurrent retroperitoneal liposarcoma. J Surg Oncol, 2018, 117(1): 62-68.
12.	Fairweather M, Gonzalez RJ, Strauss D, et al. Current principles of surgery for retroperitoneal sarcomas. J Surg Oncol, 2018, 117(1): 33-41.
13.	van Houdt WJ, Zaidi S, Messiou C, et al. Treatment of retroperitoneal sarcoma: current standards and new developments. Curr Opin Oncol, 2017, 29(4): 260-267.
14.	Raut CP, Callegaro D, Miceli R, et al. Predicting survival in patients undergoing resection for locally recurrent retroperitoneal sarcoma: a study and novel nomogram from TARPSWG. Clin Cancer Res, 2019, [Epub ahead of print].
15.	Cananzi FCM, Ruspi L, Sicoli F, et al. Did outcomes improve in retroperitoneal sarcoma surgery? Surg Oncol, 2019, 28: 96-102.
16.	Gyorki DE, Brennan MF. Management of recurrent retroperitoneal sarcoma. J Surg Oncol, 2014, 109(1): 53-59.
17.	Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol, 2009, 27(1): 31-37.
18.	吴德全. 复发性腹膜后脂肪肉瘤诊治分析. 中国实用外科杂志, 2014, 34(4): 336-338.
19.	罗成华, 金黑鹰, 苗成利, 等. 腹膜后脂肪肉瘤诊断和治疗专家共识 (2016). 中国微创外科杂志, 2016, 16(12): 1057-1063.
20.	Pisters PW. Resection of some-but not all-clinically uninvolved adjacent viscera as part of surgery for retroperitoneal soft tissue sarcomas. J Clin Oncol, 2009, 27(1): 6-8.
21.	Raut CP, Swallow CJ. Are radical compartmental resections for retroperitoneal sarcomas justified? Ann Surg Oncol, 2010, 17(6): 1481-1484.
22.	MacNeill AJ, Miceli R, Strauss DC, et al. Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: a report from the Trans-Atlantic RPS Working Group. Cancer, 2017, 123(11): 1971-1978.
23.	Chiappa A, Bertani E, Pravettoni G, et al. Aggressive surgical approach for treatment of primary and recurrent retroperitoneal soft tissue sarcoma. Indian J Surg, 2018, 80(2): 154-162.
24.	Crago AM. Extended surgical resection and histology in retroperitoneal sarcoma. Ann Surg Oncol, 2015, 22(5): 1401-1403.
25.	MacNeill AJ, Fiore M. Surgical morbidity in retroperitoneal sarcoma resection. J Surg Oncol, 2018, 117(1): 56-61.
26.	Keung EZ, Chiang YJ, Cormier JN, et al. Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma. Cancer, 2018, 124(23): 4495-4503.
27.	罗成华, 苗成利. 腹膜后肿瘤的手术治疗策略与新趋势. 中国普外基础与临床杂志, 2016, 23(3): 257-259.
28.	Maurice MJ, Yih JM, Ammori JB, et al. Predictors of surgical quality for retroperitoneal sarcoma: volume matters. J Surg Oncol, 2017, 116(6): 766-774.
29.	Toulmonde M, Bonvalot S, Méeus P, et al. Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group. Ann Oncol, 2014, 25(3): 735-742.
30.	Bonvalot S, Miceli R, Berselli M, et al. Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control. Ann Surg Oncol, 2010, 17(6): 1507-1514.
31.	Fairweather M, Wang J, Jo VY, et al. Surgical management of primary retroperitoneal sarcomas: rationale for selective organ resection. Ann Surg Oncol, 2018, 25(1): 98-106.
32.	Abdelfatah E, Guzzetta AA, Nagarajan N, et al. Long-term outcomes in treatment of retroperitoneal sarcomas: a 15 year single-institution evaluation of prognostic features. J Surg Oncol, 2016, 114(1): 56-64.
33.	Anaya DA, Lahat G, Liu J, et al. Multifocality in retroperitoneal sarcoma: a prognostic factor critical to surgical decision-making. Ann Surg, 2009, 249(1): 137-142.
34.	Wilkinson KH, Ethun CG, Hembrook M, et al. Outcomes of elderly patients undergoing curative resection for retroperitoneal sarcomas: analysis from the US sarcoma collaborative. J Surg Res, 2019, 233: 154-162.
35.	Sourrouille I, Macovei R, Faron M, et al. Long-term outcome after surgery for a localized retroperitoneal soft tissue sarcoma in elderly patients: results from a retrospective, single-center study. Ann Surg Oncol, 2018, 25(8): 2201-2208.
36.	Almond LM, Gronchi A, Strauss D, et al. Neoadjuvant and adjuvant strategies in retroperitoneal sarcoma. Eur J Surg Oncol, 2018, 44(5): 571-579.
37.	Roeder F, Alldinger I, Uhl M, et al. Intraoperative electron radiation therapy in retroperitoneal sarcoma. Int J Radiat Oncol Biol Phys, 2018, 100(2): 516-527.
38.	Constantinidou A, Jones RL. Systemic therapy in retroperitoneal sarcoma management. J Surg Oncol, 2018, 117(1): 87-92.
39.	Haas RL, Baldini EH, Chung PW, et al. Radiation therapy in retroperitoneal sarcoma management. J Surg Oncol, 2018, 117(1): 93-98.
40.	Datta J, Ecker BL, Neuwirth MG, et al. Contemporary reappraisal of the efficacy of adjuvant chemotherapy in resected retroperitoneal sarcoma: evidence from a nationwide clinical oncology database and review of the literature. Surg Oncol, 2017, 26(2): 117-124.

1. Blair AB, Reames BN, Singh J, et al. Resection of retroperitoneal sarcoma en-bloc with inferior vena cava: 20 year outcomes of a single institution. J Surg Oncol, 2018, 118(1): 127-137.
2. Tseng WW, Seo HJ, Pollock RE, et al. Historical perspectives and future directions in the surgical management of retroperitoneal sarcoma. J Surg Oncol, 2018, 117(1): 7-11.
3. Trans-Atlantic RPS Working Group. Management of primary retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group. Ann Surg Oncol, 2015, 22(1): 256-263.
4. Nussbaum DP, Rushing CN, Lane WO, et al. Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database. Lancet Oncol, 2016, 17(7): 966-975.
5. Ng D, Swallow CJ. Decision-making for palliative versus curative intent treatment of retroperitoneal sarcoma (RPS). Chin Clin Oncol, 2018, 7(4): 40.
6. Baldini E. Retroperitoneal sarcoma: setting the stage for treatment strategies tailored to histologic subtype and other patient and tumor factors. Int J Radiat Oncol Biol Phys, 2017, 99(2): 292-295.
7. Tan MC, Brennan MF, Kuk D, et al. Histology-based classification predicts pattern of recurrence and improves risk stratification in primary retroperitoneal sarcoma. Ann Surg, 2016, 263(3): 593-600.
8. Honoré C, Faron M, Mir O, et al. Management of locoregional recurrence after radical resection of a primary nonmetastatic retroperitoneal soft tissue sarcoma: the Gustave Roussy experience. J Surg Oncol, 2018, 118(8): 1318-1325.
9. Zaidi MY, Canter R, Cardona K. Post-operative surveillance in retroperitoneal soft tissue sarcoma: the importance of tumor histology in guiding strategy. J Surg Oncol, 2018, 117(1): 99-104.
10. Fairweather M, Wang J, Jo VY, et al. Incidence and adverse prognostic implications of histopathologic organ invasion in primary retroperitoneal sarcoma. J Am Coll Surg, 2017, 224(5): 876-883.
11. Bagaria SP, Gabriel E, Mann GN. Multiply recurrent retroperitoneal liposarcoma. J Surg Oncol, 2018, 117(1): 62-68.
12. Fairweather M, Gonzalez RJ, Strauss D, et al. Current principles of surgery for retroperitoneal sarcomas. J Surg Oncol, 2018, 117(1): 33-41.
13. van Houdt WJ, Zaidi S, Messiou C, et al. Treatment of retroperitoneal sarcoma: current standards and new developments. Curr Opin Oncol, 2017, 29(4): 260-267.
14. Raut CP, Callegaro D, Miceli R, et al. Predicting survival in patients undergoing resection for locally recurrent retroperitoneal sarcoma: a study and novel nomogram from TARPSWG. Clin Cancer Res, 2019, [Epub ahead of print].
15. Cananzi FCM, Ruspi L, Sicoli F, et al. Did outcomes improve in retroperitoneal sarcoma surgery? Surg Oncol, 2019, 28: 96-102.
16. Gyorki DE, Brennan MF. Management of recurrent retroperitoneal sarcoma. J Surg Oncol, 2014, 109(1): 53-59.
17. Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol, 2009, 27(1): 31-37.
18. 吴德全. 复发性腹膜后脂肪肉瘤诊治分析. 中国实用外科杂志, 2014, 34(4): 336-338.
19. 罗成华, 金黑鹰, 苗成利, 等. 腹膜后脂肪肉瘤诊断和治疗专家共识 (2016). 中国微创外科杂志, 2016, 16(12): 1057-1063.
20. Pisters PW. Resection of some-but not all-clinically uninvolved adjacent viscera as part of surgery for retroperitoneal soft tissue sarcomas. J Clin Oncol, 2009, 27(1): 6-8.
21. Raut CP, Swallow CJ. Are radical compartmental resections for retroperitoneal sarcomas justified? Ann Surg Oncol, 2010, 17(6): 1481-1484.
22. MacNeill AJ, Miceli R, Strauss DC, et al. Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: a report from the Trans-Atlantic RPS Working Group. Cancer, 2017, 123(11): 1971-1978.
23. Chiappa A, Bertani E, Pravettoni G, et al. Aggressive surgical approach for treatment of primary and recurrent retroperitoneal soft tissue sarcoma. Indian J Surg, 2018, 80(2): 154-162.
24. Crago AM. Extended surgical resection and histology in retroperitoneal sarcoma. Ann Surg Oncol, 2015, 22(5): 1401-1403.
25. MacNeill AJ, Fiore M. Surgical morbidity in retroperitoneal sarcoma resection. J Surg Oncol, 2018, 117(1): 56-61.
26. Keung EZ, Chiang YJ, Cormier JN, et al. Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma. Cancer, 2018, 124(23): 4495-4503.
27. 罗成华, 苗成利. 腹膜后肿瘤的手术治疗策略与新趋势. 中国普外基础与临床杂志, 2016, 23(3): 257-259.
28. Maurice MJ, Yih JM, Ammori JB, et al. Predictors of surgical quality for retroperitoneal sarcoma: volume matters. J Surg Oncol, 2017, 116(6): 766-774.
29. Toulmonde M, Bonvalot S, Méeus P, et al. Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group. Ann Oncol, 2014, 25(3): 735-742.
30. Bonvalot S, Miceli R, Berselli M, et al. Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control. Ann Surg Oncol, 2010, 17(6): 1507-1514.
31. Fairweather M, Wang J, Jo VY, et al. Surgical management of primary retroperitoneal sarcomas: rationale for selective organ resection. Ann Surg Oncol, 2018, 25(1): 98-106.
32. Abdelfatah E, Guzzetta AA, Nagarajan N, et al. Long-term outcomes in treatment of retroperitoneal sarcomas: a 15 year single-institution evaluation of prognostic features. J Surg Oncol, 2016, 114(1): 56-64.
33. Anaya DA, Lahat G, Liu J, et al. Multifocality in retroperitoneal sarcoma: a prognostic factor critical to surgical decision-making. Ann Surg, 2009, 249(1): 137-142.
34. Wilkinson KH, Ethun CG, Hembrook M, et al. Outcomes of elderly patients undergoing curative resection for retroperitoneal sarcomas: analysis from the US sarcoma collaborative. J Surg Res, 2019, 233: 154-162.
35. Sourrouille I, Macovei R, Faron M, et al. Long-term outcome after surgery for a localized retroperitoneal soft tissue sarcoma in elderly patients: results from a retrospective, single-center study. Ann Surg Oncol, 2018, 25(8): 2201-2208.
36. Almond LM, Gronchi A, Strauss D, et al. Neoadjuvant and adjuvant strategies in retroperitoneal sarcoma. Eur J Surg Oncol, 2018, 44(5): 571-579.
37. Roeder F, Alldinger I, Uhl M, et al. Intraoperative electron radiation therapy in retroperitoneal sarcoma. Int J Radiat Oncol Biol Phys, 2018, 100(2): 516-527.
38. Constantinidou A, Jones RL. Systemic therapy in retroperitoneal sarcoma management. J Surg Oncol, 2018, 117(1): 87-92.
39. Haas RL, Baldini EH, Chung PW, et al. Radiation therapy in retroperitoneal sarcoma management. J Surg Oncol, 2018, 117(1): 93-98.
40. Datta J, Ecker BL, Neuwirth MG, et al. Contemporary reappraisal of the efficacy of adjuvant chemotherapy in resected retroperitoneal sarcoma: evidence from a nationwide clinical oncology database and review of the literature. Surg Oncol, 2017, 26(2): 117-124.

Previous Article
Updates on non-surgical treatments of the enterocutaneous fistula
Next Article
胸外科围手术期肺保护中国专家共识（2019 版）

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Predictive factors for recurrence of retroperitoneal sarcoma

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content